• SmartestCrowd
    • No organizations
    • No projects
0
0
FDA Approves First Biosimilar to Treat Multiple Sclerosis - FDA.gov
8/24/23 at 9:00pm
Organization
FDA.gov
Author
Office of the Commissioner
29 words
0
Comments
FDA has approved the first biosimilar to Tysabri (natalizumab) injection for the treatment of relapsing forms of multiple sclerosis.
You are the first to view
https://www.fda.gov/news-events/press-announcements/fda-approves-first-biosimilar-treat-multiple-sclerosis
Create an account or login to join the discussion